BMPR1B

mass-spec protein & survival
Survivalmass-specKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, BMPR1B mass-spec protein is linked to patient survival in 1 of 34 cancer types, making it a survival-associated BMPR1B data layer compared with 22 for mass-spec protein and 5 for mutation status.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher BMPR1B mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated BMPR1B expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

UCEC are the cancer types where BMPR1B mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
UCECOSMedianII,III,IV1.0000.484.0494view →
Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

BMPR1B–UCEC (OS)

Kaplan–Meier survival curve for BMPR1B mass-spec protein-high vs -low samples in UCEC.

Open the UCEC breakdown →

Exploration